+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

Erythropoietin Stimulating Agents Market 2024-2028 - Product Thumbnail Image

Erythropoietin Stimulating Agents Market 2024-2028

  • Report
  • October 2024
  • 137 Pages
  • Global
From
Polycystic Kidney Disease Drugs Market 2024-2028 - Product Thumbnail Image

Polycystic Kidney Disease Drugs Market 2024-2028

  • Report
  • July 2024
  • 141 Pages
  • Global
From
Homocystinuria - Pipeline Insight, 2025 - Product Thumbnail Image

Homocystinuria - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Kidney Transplant Rejection - Pipeline Insight, 2025 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Anemia Associated With Chronic Kidney - Pipeline Insight, 2025 - Product Thumbnail Image

Anemia Associated With Chronic Kidney - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hepatitis B - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatitis B - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Alcoholic Steatohepatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Alcoholic Steatohepatitis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Hepatitis C Virus Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Hepatitis C Virus Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 75 Pages
  • Global
From
Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2025 - Product Thumbnail Image

Clear Cell Renal Cell Carcinoma (ccRCC) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Liver Disease Associated Pruritus - Pipeline Insight, 2025 - Product Thumbnail Image

Liver Disease Associated Pruritus - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Hepatic Cirrhosis - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatic Cirrhosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Liver Fibrosis- Pipeline Insight, 2025 - Product Thumbnail Image

Liver Fibrosis- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 85 Pages
  • Global
From
Oncocytoma - Pipeline Insight, 2025 - Product Thumbnail Image

Oncocytoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Renal Impairment - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Impairment - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Polycystic Kidney Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Polycystic Kidney Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Liver Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Liver Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Renal Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Late-stage Chronic Kidney Disease (CKD) - Pipeline Insight, 2025 - Product Thumbnail Image

Late-stage Chronic Kidney Disease (CKD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Nephropathic Cystinosis - Pipeline Insight, 2025 - Product Thumbnail Image

Nephropathic Cystinosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Renal/Kidney Transplant Rejection - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Renal/Kidney Transplant Rejection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more